This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n10http://linked.opendata.cz/resource/drugbank/drug/DB07207/identifier/pdb/
n11http://linked.opendata.cz/resource/drugbank/drug/DB07207/identifier/pubchem-compound/
n14http://bio2rdf.org/drugbank:
n9http://linked.opendata.cz/resource/drugbank/drug/DB07207/identifier/pubchem-substance/
admshttp://www.w3.org/ns/adms#
n13http://linked.opendata.cz/resource/drugbank/drug/DB07207/identifier/drugbank/
n6http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
n12http://linked.opendata.cz/resource/drugbank/drug/DB07207/identifier/chemspider/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB07207
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB07207 n14:DB07207
dcterms:title
2-(4-HYDROXY-5-PHENYL-1H-PYRAZOL-3-YL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE
adms:identifier
n9:99443678 n10:6NH n11:6420178 n12:20139330 n13:DB07207
n3:IUPAC-Name
n4:271B548C-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B5492-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B5491-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B548E-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B548F-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5490-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B548A-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B548B-363D-11E5-9242-09173F13E4C5 n4:271B5488-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B5489-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B5498-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5499-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B5493-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B5494-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B5496-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B5495-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B5497-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B549E-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B54A0-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B54A1-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B549D-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B549C-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B549F-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B548D-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B549A-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B549B-363D-11E5-9242-09173F13E4C5